Clinical Trials Logo

Critical Illness clinical trials

View clinical trials related to Critical Illness.

Filter by:

NCT ID: NCT03800628 Recruiting - Quality of Life Clinical Trials

Resource Availability Following Critical Illness

Start date: December 7, 2018
Phase:
Study type: Observational

The purpose of this qualitative study is to explore the vital issues in recovery of QOL from the perspective of survivors of critical illness and understand these patients' views on rehabilitative services in the United States (U.S.). The theoretical framework for this study is Max Weber's Rational Choice Theory (RCT). The research questions will focus on understanding post-ICU QOL and the patients' experience with rehabilitative services following critical illness. A phenomenological study design is being employed, using semi-structured individual interviews with critical illness survivors. Data from the interviews will be coded for thematic analysis. The implications for social change include defining the meaning of QOL for an ICU survivor and improving healthcare policies for the therapies necessary to return survivors to a life worth living.

NCT ID: NCT03798600 Completed - Critical Illness Clinical Trials

Pharmacokinetics/Pharmacodynamics (PK/PD) of Caspofungin in Intensive Care Unit (ICU) Patients. An Open Observational Study for Antifungal Treatment's Optimization

Start date: January 1, 2016
Phase:
Study type: Observational

PK of Caspofungin in ICU septic patients might be changed as compared to healthy volunteers due to sepsis-related pathophysiology. Sub-optimal plasma and tissue concentrations might be achieved in these patients when drugs are administered at the same dosage/regimen suggested for healthy volunteers.

NCT ID: NCT03796338 Completed - Critical Illness Clinical Trials

Sleep Quantity and Quality in the ICU: a Prospective Observational Stud

Start date: February 1, 2018
Phase:
Study type: Observational

Several evidences in the literature suggest sleep interruption in critical care patients. Nowadays, the amount and the quality of sleep phases during the length of stay in the intensive care unit are largely unknown. In this study, the amount of time spent by the patients in N1, N2 N3 and REM phases during sleep is quantified.

NCT ID: NCT03793257 Recruiting - Cardiac Arrest Clinical Trials

The EXCEL Registry of Patients Requiring ECMO

Start date: February 1, 2019
Phase:
Study type: Observational [Patient Registry]

ECMO is associated with significant costs, risks and requires specialist training and expertise. EXCEL is a novel, high-quality, detailed prospective registry of patients requiring ECMO in Australia and New Zealand. The registry provides information on patient selection, complications, costs and patient reported outcome measures. EXCEL uses the Theoretical Domains Framework to identify evidence-practice gaps and explore barriers and enablers to tailor implementation of evidence

NCT ID: NCT03793244 Completed - Critical Illness Clinical Trials

TARGET-Metabolic Effects

TARGET-ME
Start date: July 1, 2017
Phase:
Study type: Observational

The estimation of calorie needs during routine practice in critically ill patients is highly variable and the thermogenic effect of continuous delivery of enteral nutrition (EN) on overall calorie utilisation in critically ill adults is unknown. The TARGET-ME study is a substudy of the TARGET trial (NCT02306746). The TARGET trial provides the perfect opportunity to measure calorie utilisation via indirect calorimetry (IC) and ventilator-derived carbon dioxide production (VCO2) to compare measured calorie utilisation to estimation methods, determine the potential thermic effect of EN solutions with different energy concentrations and investigate any associations with outcome.

NCT ID: NCT03791801 Recruiting - Critical Illness Clinical Trials

The Use of Sugammadex in the Critically Ill

Start date: September 1, 2019
Phase: N/A
Study type: Interventional

Moderate and Deep neuromuscular blockade (rocuronium administered to a train of four count 0 and post-tetanic count of 1-2) in critically ill patients needing intubation or procedures can be reversed immediately and effectively by sugammadex avoiding unnecessary paralysis in an already weakened population

NCT ID: NCT03789396 Completed - Critical Illness Clinical Trials

Pilot Study of Targeted Normoxia in Critically Ill Trauma Patients

Start date: January 1, 2018
Phase:
Study type: Observational [Patient Registry]

The objective of this study is to conduct an observational pre/post study to evaluate the clinical impact oxygen guideline implementation on oxygen utilization and oxygenation in critically ill trauma patients.

NCT ID: NCT03789305 Completed - Critical Illness Clinical Trials

Differences in Frail and Non-frail Critically-ill Patients in Functional Outcomes

DEFAULT
Start date: April 1, 2017
Phase:
Study type: Observational

This is a prospective analysis of patient registry data of intensive care patients. The aim is to investigate if frailty is a predictor of decline of functional status of critically ill patients during their hospital stay.

NCT ID: NCT03788096 Recruiting - Sepsis Clinical Trials

Peer Support for Post Intensive Care Syndrome Self-Management

PS-PICS
Start date: April 20, 2020
Phase: N/A
Study type: Interventional

A prospective, 2-arm, single-blind, randomized controlled clinical feasibility trial design is planned. Forty CCI survivors will be randomized (1:1) to either the PS-PICS (peer support) intervention or usual care (control) group.

NCT ID: NCT03787810 Completed - Clinical trials for Acute Coronary Syndrome

Left Ventricular Dysfunction in Critically Ill Patients

LEVEDYCIP
Start date: May 28, 2018
Phase:
Study type: Observational

Left ventricular dysfunction is common in the critically ill. The aim of this study is to assess the incidence and prognosis of left ventricular dysfunction in critically ill patients.